Travis Corbitt's struggles to breathe led to his retirement and reliance on an oxygen tank.

A European study finds hospitalisations and insufficient growth reduce health-related quality of life in childhood ...

Proton pump inhibitor (PPI) use in patients with chronic obstructive airway diseases is associated with an increased exacerbation risk.

By Sahil Pandey and Siddhi Mahatole Feb 23 (Reuters) - Gossamer Bio's experimental treatment failed to significantly improve ...

Harriet Davidson is challenging herself to run four marathons in four days.

Regulatory officials have granted Molbreevi priority review and assigned a goal date of Aug. 22, 2026. If approved, Molbreevi will be priced between $400,000 and $500,000 per year.

Rare lung diseases affect people nationwide, yet many patients go undiagnosed or misdiagnosed for years. One rare lung disease that illustrates the challenges of timely diagnosis is autoimmune pulmona ...

DOCTOR, WHEN YOU GET SICK, WOMEN ARE MORE LIKELY TO EXPERIENCE CERTAIN LUNG RELATED SYMPTOMS THAN MEN. JOINING US THIS MORNING WITH MORE IS MERCY MEDICAL CENTER PULMONOLOGIST DOCTOR ANTHONY ROWE. GOOD ...

Gossamer Bio's drug for pulmonary arterial hypertension failed to achieve the primary endpoint of a Phase 3 clinical trial.

Cutting down outdoor exercise is a natural response this frigid winter, especially for lung patients. However, to keep their ...